KATHLEEN RISLEY: Open Payments
NPI 1245266659 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$368 in 20 payments from 10 companies in 2025. Trend: 2023 $657 · 2024 $625 · 2025 $368
Food & beverage: $368
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 4 | $80 |
| Evofem Biosciences, Inc. | 3 | $52 |
| MILLICENT US INC | 3 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| Sumitomo Pharma America, Inc. | 2 | $38 |
| Exeltis, USA Inc. | 2 | $33 |
| Sage Therapeutics, LLC | 1 | $22 |
| ABBVIE INC. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $17 |
| Novo Nordisk Inc | 1 | $15 |
Products named: Phexxi, MYFEMBREE, FEMLYV, SLYND, Mirena, ZURZUVAE, QULIPTA, INTRAROSA.
Industry payments across MO — which companies pay providers there.
